Weight Gain and Cardiovascular Risk After Organ Transplantation
Organ transplantation has become a common and effective approach to the management of patients with organ failure. The improvement in long-term survival has resulted in the emergence of cardiovascular disease as the primary cause of death in renal transplant patients and a significant complication i...
Saved in:
Published in: | JPEN. Journal of parenteral and enteral nutrition Vol. 25; no. 3; pp. 114 - 119 |
---|---|
Main Author: | |
Format: | Journal Article |
Language: | English |
Published: |
Thousand Oaks, CA
Sage Publications
01-05-2001
SAGE Publications ASPEN American Society for Parenteral and Enteral Nutrition |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Organ transplantation has become a common and effective approach to the management of patients with organ failure. The improvement in long-term survival has resulted in the emergence of cardiovascular disease as the primary cause of death in renal transplant patients and a significant complication in other organ recipients. A number of factors explain this trend, including a high incidence of hypertension, posttransplant diabetes, hyperlipidemia, and obesity risk factors that are mediated by direct effects of immunosuppressive medications. Weight gain posttransplant affects ~50% of patients and represents a significant problem because of the potential synergism between obesity and immunosuppressive medication-induced effects on cardiovascular disease risk factor development. This review discusses the incidence and implications of cardiovascular disease risk factors in organ transplant recipients, strategies for clinical management, and future research directions. (Journal of Parenteral and Enteral Nutrition 25:114-119, 2001) |
---|---|
ISSN: | 0148-6071 1941-2444 |
DOI: | 10.1177/0148607101025003114 |